Advanced Proteome Therapeutics Corporation: Company Targets Off-Patent, High Value, Protein Therapeutics in 20-F Filing

February 22, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

BOSTON, MASSACHUSETTS--(Marketwire - February 22, 2008) - Advanced Proteome Therapeutics Corporation (APT) (TSX VENTURE: APC), an emerging biotechnology company, today issues update in conjunction with the filing of a 20F Annual Report for FY 2007.

Twitter
LinkedIn
Facebook
Email
Print